Educational information, not financial advice or a personal recommendation. Not regulated by the FCA. Do your own research. Capital at risk.

Convatec Group PLC (CTEC.L)

Healthcare Balanced

Convatec is a British medical products company that helps people manage chronic conditions like wounds, ostomies, and bladder issues.

£2.24

Is Convatec Group PLC a good stock for a UK beginner?

The honest version: Convatec is a British medical products company that helps people manage chronic conditions like wounds, ostomies, and bladder issues.

No rating · no target price · nothing for sale here
Price-4.4%
52-week range-9% past year
£2.24
Low £1.93High £2.59
Where today's price sits versus its past year - context, not a signal.
If you had put £1,000 into Convatec Group PLC
£956-4%

Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. Past performance is not a guide to the future, and it could just as easily have fallen.

Market cap: The company's total value on the stock market - share price times the number of shares. Big = 'large-cap', small = 'small-cap'.
£4.38B
Avg volume: How many shares change hands on a typical day. Higher means it's easy to buy or exit without moving the price.
8.22M
Day range: The lowest and highest price the shares traded at during the latest day.
£2.24 – £2.30
52-week range: The lowest and highest the shares have traded over the past year - a sense of how wide the swings have been.
£1.93 – £2.59
P/E ratio: Price-to-earnings: the share price divided by yearly profit per share. Lower can mean cheaper; higher often means investors expect fast growth.
37.3
Dividend yield: The yearly dividend as a percentage of the share price - roughly the income you'd earn from dividends alone.
2.4%
Beta: How bumpy the share price is versus the whole market. Above 1 swings more than the market; below 1 is calmer. It's about the ride, not whether it goes up or down.
0.76
How bumpy is it?Beta: How bumpy the share price is versus the whole market. Above 1 swings more than the market; below 1 is calmer. It's about the ride, not whether it goes up or down. 0.76
Calm
Wild
Steadier than most

Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.

Why has it been moving?▲ +1% past week · ▼ -9% past year

Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.

The bull case

Aging global population drives sustained demand for chronic care.

The bear case

Significant loss of patent protection or pricing power.

What does Convatec Group PLC do?

Convatec makes the essential medical supplies that patients use every day to manage long-term health conditions, such as bandages for complex wounds or equipment for those living with an ostomy. Sales to hospitals, and directly to patients through healthcare providers, bring in the money. Look at whether they can grow sales while reining in manufacturing costs, having invested heavily in new technology to boost their efficiency.

VQGMI
Factor profile

On our factor screen it looks strongest on quality and value, and weakest on growth.

Value: How cheap the stock looks versus profits, sales and assets (higher = cheaper). 41Quality: How profitable and financially healthy the company is (higher = stronger). 49Growth: How fast revenue and earnings are growing (higher = faster). 34Momentum: How the share price has been trending recently (higher = stronger recent run). 36Income: The dividend income on offer and how sustainable it looks (higher = more/steadier). 37
Quick checks
What's strong
  • Essential products that people need regardless of the economy
  • Strong gross margins showing efficient production
  • Lower volatility compared to the broader market
What to watch
  • Pressure from healthcare providers to lower prices
  • Rising costs of raw materials and logistics
  • Regulatory hurdles for new medical devices

What do Convatec Group PLC's numbers mean?

P/E
30.3
This shows how much investors are currently paying for every pound of the company's recent profit, reflecting high expectations for future earnings.
Gross margin
56.3%
This tells us that for every pound of product sold, the company keeps over 56 pence after paying for the direct costs of making it.
Dividend yield
2.5%
This is the annual cash payout to shareholders as a percentage of the share price, providing a modest regular income stream.
Beta
0.8
A number below 1 suggests the share price tends to be less jumpy than the wider stock market.

Does Convatec Group PLC pay a dividend?

Yes - Convatec Group PLC currently pays a dividend of about 2.4% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.

More in Healthcare

Eli LillyWest Pharmaceutical Services, Inc.Incyte CorporationThe Cigna GroupZimmer Biomet Holdings, Inc.Moderna, Inc.Gilead Sciences, Inc.Regeneron Pharmaceuticals, Inc.

What are the scenarios for Convatec Group PLC?

An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.

£3£2£2today · £2▲ Bull · £2• Base · £2▼ Bear · £2in 1 yearILLUSTRATIVE · NOT A PREDICTION OR PRICE TARGET
Bull
+5% to +10%Stronger demand for advanced wound care products.
Base
-2% to +2%Steady, predictable sales in core markets.
Bear
-5% to -10%Higher costs eating into profit margins.

What are the pros and cons of Convatec Group PLC?

3bull points
6bear points

How many points the write-up makes each way — a balance check, not a score or verdict.

The bull case3
  • Essential products that people need regardless of the economy
  • Strong gross margins showing efficient production
  • Lower volatility compared to the broader market
The catch3
  • Recent drop in earnings growth
  • High current price relative to recent profits
  • Relatively low net profit margin
Key risks3
  • Pressure from healthcare providers to lower prices
  • Rising costs of raw materials and logistics
  • Regulatory hurdles for new medical devices
What would flip the thesis

The write-up's own warning lights — if these start happening, the case above changes.

Confidence: medium · data: GBP · flags: none · Charts by TradingView Lightweight Charts™
Found this useful? The Almanac is free and ad-free - a coffee keeps it that way.Support →

Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →

This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.

Figures as of 2026-08-01. Prices may be delayed and numbers can go stale - always double-check before acting.